Engineered Bacterial Outer Membrane Vesicles-Based Doxorubicin and CD47-siRNA Co-Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma

已完结 10 由 111111 发布于 2025/12/2 20:52:57

DOI:10.1002/adma.202418053
作者：Haoyu You,?Shilin Zhang,?Yiwen Zhang,?Qinjun Chen,?Yuxing Wu,?Zheng Zhou,?Zhenhao Zhao,?Boyu Su,?Xuwen Li,?Yun Guo,?Yun Chen,?Weiyi Tang,?Bing Liu,?Hongrui Fan,?Shuo Geng,?Mingzhu Fang,?Fangxin Li,?Gu
文献类型：期刊论文
补充材料：只需要正文

Wiley

Abstract：Apart from the blood-brain barrier (BBB), the efficacy of immunotherapy for glioblastoma (GBM) is limited by the presence of intrinsic and adaptive immune resistance, implying that co-delive

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Relationship between biodiversity and ecosystem functioning in alpine meadows of the Qinghai-Tibet Plateau